TRPV1 and neuropathy: Here,we report for the first time a series of compoundspotentiallyuseful for the management of oxaliplatin-induced neuropathy (OINP)able to modulate the human Carbonic Anhydrases (hCAs) as well as theTransient Receptor Potential Vanilloid 1 (TRPV1).